Robin Robinson, PhD is the Deputy Assistant Secretary for Preparedness and Response (ASPR) and the first Director for the Biomedical Advancement Research and Development Authority (BARDA) since 2008 within the U.S. Department of Health and Human Services (HHS), BARDA supports countermeasure development, acquisition and domestic manufacturing production. Robinson joined HHS from the pharmaceutical industry in May 2004 as the Director of Influenza and Emerging Diseases Division within BARDA’s predecessor agency. Robinson received a Bachelor degree in Biology from Millsaps College, a Doctoral degree from the University of Mississippi Medical School in Medical Microbiology with a dissertation on herpesvirus oncogenesis, and postdoctoral fellowships from the State University of New York at Stony Brook on viral oncogenesis. While on faculty in the Department of Microbiology and Immunology at the University of Texas Southwestern Medical School, he investigated the molecular pathogenesis of herpes viruses and HIV gene expression, latency, and replication. Later at the National Cancer Institute, he continued molecular studies on HIV gene regulation. Afterwards in the pharmaceutical industry for more than twelve years, he developed and patented platform vaccine technologies including virus-like particle and subunit protein vaccines for human papillomaviruses, rotavirus, influenza virus, Norwalk virus, hepatitis E, and HIV. Robinson also serves on World Health Organization’s expert teams on pandemic influenza vaccines and the editorial board of several peer review journals.